Drugs / Refresh Optive Mega-3 PF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05705518 Comparator | Jan → Sep 2023 | dry eye syndrome | University of California, Berkeley | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Refresh Optive Mega-3 PF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05705518 ↗ |
| Route | Other | “artificial tear drops” NCT05705518 ↗ |